Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Astrazeneca PLC Transaction History

Yahav Achim Ve Achayot Provident Funds Management CO Ltd.

$35.2 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $555,720 - $630,080	-8,800 Reduced 38.94%	13,800 $957,000
Q3 2021 Nov 17, 2021	BUY	$55.56 - $60.79 $1.26 Million - $1.37 Million	22,600 New	22,600 $1.36 Million

Others Institutions Holding AZN

# of Institutions

1,336

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.46 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.98 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.64 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.61 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.36 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yahav Achim Ve Achayot Provident Funds Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yahav Achim Ve Achayot Provident Funds Management CO Ltd. with notifications on news.

Account